Michi
Shinohara
MD
Department of Dermatology
UW Medical Center
1959 NE Pacific St.
BB-1332 Health Sciences
Box 356524
Seattle, WA 98195
Appointments
UW Medical Center – Roosevelt Dermatology Center
206.598.4067
Schedule Online
Fred Hutch Cancer Center
855.557.0555
Schedule Online
South Lake Union Clinic
825 Eastlake Ave E
Seattle, WA 98109
Dermatopathology Consultations
Please visit the Department of Laboratory Medicine & Pathology and submit a Pathology Service Request Form.
Biography
Dr. Michi Shinohara attended Reed College in Portland, Oregon, starting as an art major, but falling victim to the geeky-cool lure of the sciences and graduating majoring in Chemistry. She attended the University of Washington School of Medicine in Seattle. Her broad interests led her first to internal medicine residency at the University of Washington, however, exposure to dermatology clinics during her medicine residency led to a second residency in dermatology. After a dermatopathology fellowship at the University of Pennsylvania, she returned to the Seattle area to join the faculty at University of Washington in 2010, where she has dual appointments within Dermatology and Dermatopathology.
Dr. Shinohara specializes in the care of patients with cutaneous lymphoma, and maintains a multidisciplinary Cutaneous Lymphoma Clinic at the Fred Hutchinson Cancer Center. She serves as director of the Dermatopathology Service and is the Program Director for the Dermatopathology Fellowship at University of Washington. Her research interests are health related quality of life for patients with cutaneous lymphoma, and she also focuses on mentorship and sponsorship of women and those who are historically excluded in medicine.
Dr. Shinohara serves on the Board of Directors of the Women’s Dermatology Society and United States Cutaneous Lymphoma Consortium, and is active in the Association of Professors of Dermatology and the American Society for Dermatopathology.
Education & Training
MD, University of Washington School of Medicine, Seattle WA (1998-2002)
Internship and Residency in Internal Medicine, University of Washington Department of Internal Medicine, Seattle WA (2002-2005)
Dermatology Residency, University of Washington, Seattle WA (2006-2009)
Fellowship in Dermatopathology, University of Pennsylvania, Philadelphia PA (2006-2009)
B.A. in Biochemistry, Reed College , Portland OR (1990-1994)
Honors
Chief Resident, University of Washington Department of Dermatology Residency (2008-2009) (Alpha Omega Alpha)
American Academy of Dermatology Leadership Forum selectee (2017)
Chief of Medicine Service Award, University of Washington Department of Medicine (2016)
UW Derm John Olerud Resident Teaching Award (2015)
Seattle Top Docs (Seattle Met Magazine) (2020)
Research Interests
- Cutaneous lymphomas clinical trials
- Quality of life in cutaneous lymphoma
- Gender gap in dermatology
- Medical education
- Assorted projects with trainees - including projects around dermpath/inpatient derm
Clinical Interests
- Cutaneous lymphomas
- Dermatopathology
- Teaching and medical education
Publications
Selected Publications
Shinohara MM, Mahurin HM, Tarabadkar E, et al. Health-related quality of life in cutaneous T-cell lymphoma: A cross-sectional survey study. Skin Health and Disease. May 2021.
Ware OR, Coolman TD, Shinohara MM. Dermatologist Burnout: Contribution of gender and impact of children. JAAD, accepted for publication February 3, 2020.
Guest Editor, special “Gender Gap” issue, International Journal of Women’s Dermatology, Jan 2020.
Jacobsen E, Hippe DS, Lachance K, Perrone ME, Chang OH, Shinohara MM. Should Margin Status of Biopsies be Included in Dermatopathology Reports? Clinician Preferences and the Importance of Unambiguous Language. Am J Dermatopathol Accepted for Publication Sept 2019.
Ware O, Tarabadkar ES, Shustov A, Shinohara MM. Pralatrexate for refractory or recurrent subcutaneous panniculitis-like T-cell lymphoma with hemophagocytic syndrome. JAAD, 2019 Jul 15. pii: S0190-9622(19)32379-5.
Shinohara MM, Shustov A. How I treat primary cutaneous CD30+ lymphoproliferative disorders. Blood, 2019 Aug 8;134(6):515-524.